Fei Yi
Fei Yi
Ambys Medicines
Verified email at
Cited by
Cited by
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging
W Zhang, J Li, K Suzuki, J Qu, P Wang, J Zhou, X Liu, R Ren, X Xu, ...
Science 348 (6239), 1160-1163, 2015
Mitochondrial regulation in pluripotent stem cells
X Xu, S Duan, F Yi, A Ocampo, GH Liu, JCI Belmonte
Cell metabolism 18 (3), 325-332, 2013
Repression of Nanog gene transcription by Tcf3 limits embryonic stem cell self-renewal
L Pereira, F Yi, BJ Merrill
Molecular and cellular biology 26 (20), 7479-7491, 2006
Progressive degeneration of human neural stem cells caused by pathogenic LRRK2
GH Liu, J Qu, K Suzuki, E Nivet, M Li, N Montserrat, F Yi, X Xu, S Ruiz, ...
Nature 491 (7425), 603-607, 2012
Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell self-renewal
F Yi, L Pereira, JA Hoffman, BR Shy, CM Yuen, DR Liu, BJ Merrill
Nature cell biology 13 (7), 762-770, 2011
Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs
GH Liu, K Suzuki, J Qu, I Sancho-Martinez, F Yi, M Li, S Kumar, E Nivet, ...
Cell stem cell 8 (6), 688-694, 2011
Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons
F Yi, T Danko, SC Botelho, C Patzke, CH Pak, M Wernig, TC Südhof
Science 352 (6286), aaf2669, 2016
Tcf3 functions as a steady-state limiter of transcriptional programs of mouse embryonic stem cell self-renewal
F Yi, L Pereira, BJ Merrill
Stem cells 26 (8), 1951-1960, 2008
Human neuropsychiatric disease modeling using conditional deletion reveals synaptic transmission defects caused by heterozygous mutations in NRXN1
CH Pak, T Danko, Y Zhang, J Aoto, G Anderson, S Maxeiner, F Yi, ...
Cell stem cell 17 (3), 316-328, 2015
Canonical Wnt/β-catenin regulation of liver receptor homolog-1 mediates pluripotency gene expression
RT Wagner, X Xu, F Yi, BJ Merrill, AJ Cooney
Stem cells 28 (10), 1794-1804, 2010
PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype
S Duan, G Yuan, X Liu, R Ren, J Li, W Zhang, J Wu, X Xu, L Fu, Y Li, ...
Nature communications 6 (1), 1-14, 2015
Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs
GH Liu, K Suzuki, M Li, J Qu, N Montserrat, C Tarantino, Y Gu, F Yi, X Xu, ...
Nature communications 5 (1), 1-17, 2014
CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs
L Wang, F Yi, L Fu, J Yang, S Wang, Z Wang, K Suzuki, L Sun, X Xu, Y Yu, ...
Protein & Cell 8 (5), 365-378, 2017
Efficient correction of hemoglobinopathy-causing mutations by homologous recombination in integration-free patient iPSCs
M Li, K Suzuki, J Qu, P Saini, I Dubova, F Yi, J Lee, I Sancho-Martinez, ...
Cell research 21 (12), 1740-1744, 2011
Direct conversion of human fibroblasts into retinal pigment epithelium-like cells by defined factors
K Zhang, GH Liu, F Yi, N Montserrat, T Hishida, CR Esteban, ...
Protein & cell 5 (1), 48-58, 2014
Human induced pluripotent stem cells derived hepatocytes: rising promise for disease modeling, drug development and cell therapy
F Yi, GH Liu, JCI Belmonte
Protein & cell 3 (4), 246-250, 2012
Analysis of conditional heterozygous STXBP1 mutations in human neurons
C Patzke, Y Han, J Covy, F Yi, S Maxeiner, M Wernig, TC Südhof
The Journal of clinical investigation 125 (9), 3560-3571, 2015
Rapid and highly efficient generation of induced pluripotent stem cells from human umbilical vein endothelial cells
AD Panopoulos, S Ruiz, F Yi, A Herrerías, EM Batchelder, JCI Belmonte
PloS one 6 (5), e19743, 2011
Progress and prospects in stem cell therapy
X Xu, F Yi, H Pan, S Duan, Z Ding, G Yuan, J Qu, H Zhang, G Liu
Acta Pharmacologica Sinica 34 (6), 741-746, 2013
Establishment of hepatic and neural differentiation platforms of Wilson’s disease specific induced pluripotent stem cells
F Yi, J Qu, M Li, K Suzuki, NY Kim, GH Liu, JCI Belmonte
Protein & cell 3 (11), 855-863, 2012
The system can't perform the operation now. Try again later.
Articles 1–20